series-a
Stage
2025
Founded
1
Investors
About
transcripta bio is a German biotech startup developing a novel platform for the discovery of RNA-targeting small molecules. Their mission is to unlock the full potential of RNA as a drug target to address previously undruggable diseases.
Explore transcripta bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.